10月29日，南方医院心血管内科修建成团队成功应用国产肾神经标测/选择性消融系统为一例难治性高血压和一例药物不耐受高血压患者施行经肾动脉去肾交感神经术 (renal ...

Medtronic and Recor Medical may have some fresh resolutions for the new year after the Centers for Medicare & Medicaid ...

Furthermore, as there is no evidence of benefit of renal denervation in poorly compliant patients, drug adherence should be evaluated using validated questionnaires or, preferably, dosage of drug ...

With a focus on innovation, patient-centered care, and collaboration, Pulnovo Medical, a rising star in the realm of ...

This may adversely affect both future cardiovascular events and mortality. Catheter-based renal denervation is a promising contemporary evolution of a historical treatment for hypertension and ...

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

The U.S. Medicare outpatient final rule affirms several new devices for the new technology pass-through program, but one of the more significant findings is that CMS will use separate payment ...

About a year ago, renal denervation procedures won a huge victory after finally being greenlit by FDA. Now two of the frontrunners in the space have received reimbursement.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted transitional pass-through (TPT) payment for the ...

Patient and physician education is the next challenge to change the treatment paradigm for drug-resistant hypertension, Citi Research analyst Joanne Wuensch said.